|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current Assets: | |||||||
| Cash and cash equivalents | |||||||
| Prepaid expenses | |||||||
| Expense reimbursement receivable | |||||||
| Dividends receivable from operating account | |||||||
| Total Current Assets | |||||||
| Forward Purchase Agreement assets | |||||||
| Cash and marketable securities held in Trust Account | |||||||
| Dividend receivable from Trust Account | |||||||
| Total Assets | |||||||
| Liabilities and Stockholders' Deficit | |||||||
| Current Liabilities: | |||||||
| Accrued expenses | |||||||
| Accrued offering costs | |||||||
| Income taxes payable | |||||||
| Due to related party | |||||||
| Total Current Liabilities | |||||||
| Forward Purchase Agreement liabilities | |||||||
| Outstanding Warrant liabilities | |||||||
| Deferred income taxes payable | |||||||
| Deferred underwriting fees payable | |||||||
| Total Liabilities | |||||||
| Class A Common Stock, $0.0001 par value, 200,000,000 shares subject to possible redemption at redemption value | |||||||
| Common Class A | |||||||
| Total class A Common Stock, $0.0001 par value, 200,000,000 shares subject to possible redemption at redemption value | |||||||
| Common stock | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Stockholders' Deficit | |||||||
| Common Class A | |||||||
| Common Class B | |||||||
| Total Stockholders' Deficit | |||||||
| Total Liabilities, Class A Common Stock Subject to Possible Redemption and Shareholders' Deficit |
Loading...